clinical research

inter

plantmedicine

poster sessions

 

New research on the use of psychedelic drugs as treatment for a range of mental disorders appears to be throwing open doors of perception long closed within the medical community.
Los Angeles Times, September 2015

Discover the latest research into the benefits and risks of psychedelics and marijuana for psychotherapy, neuroscience, spirituality, and creativity, and more.

The Three-Day Conference (April 21-23) will feature three simultaneous tracks of presentations by leading and up-and-coming international researchers in the multidisciplinary field of psychedelic science and medicine. Presenters from around the world will share recently completed and ongoing research into the therapeutic, scientific, and spiritual uses of:

  • MDMA
  • LSD
  • Ayahuasca
  • Psilocybin
  • Ibogaine
  • Ketamine
  • Peyote
  • Medical marijuana
...and much more!


Clinical Research Track

Rick Doblin, Ph.D.
The Future of Psychedelic Therapy

 


Roland Griffiths, Ph.D.
Overview of the Johns Hopkins Psilocybin Research Project

 


Stan Grof, M.D.
Past and Future of Psychedelic Therapy

 


Amanda Feilding
Breakthroughs in Psychedelic Research from the Beckley Foundation

 


 


Matthew Johnson, Ph.D.
Psychedelics as Behavior Change Agents: Addiction Recovery and Beyond

 


 


David Nichols, Ph.D.
Psychedelic Neuroscience

 


David Nutt, M.D.
Psychedelic Research at the Beckley/Imperial Research Programme

 


 


 


 


Interdisciplinary Research Track

 


James Fadiman, Ph.D., and Sophia Korb, Ph.D.
Preliminary Results from Psychedelic Microdosing Study

 


Katherine Hendy
The Placebo Paradox

 


Ethan Nadelmann, Ph.D.
Drug Policy and Psychedelics

 


Claudio Naranjo, M.D.
Interpersonal Psychedelics

 


Paul Stamets
Mushroom Mycology

 


 


Plant Medicine Track

Organized by Bia Labate, Ph.D.

 


 


 


 


 


 


 


 


alexander dawson headshot

Alexander Dawson, Ph.D.
Peyote's Race Problem

 


 


 


 


 


 


 


 


 


 


o hayden griffin

O. Hayden Griffin, III, Ph.D.
The Therapeutic Potential of Kratom

 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


graham st john

Graham St. John, Ph.D.
DMT, Liminality, and Hyperspace

 


 


 

MORE SPEAKERS COMING SOON

Share This Page